Eisai Co., Ltd.

1% Holds the Key to the Future

Recognizing that patients and consumers are the key players in healthcare, all employees are recommended to spend 1% of their working hours with patients

Eisai's hhc Philosophy

Recognizing that patients and consumers are the key players in healthcare, all employees are recommended to spend 1% of their working hours with patients
Eisai at a Glance

Eisai at a Glance
Making Our Medicines Available to Those Who Need Them

We strive to improve access to medicines through the development and provision of innovative medicines.

Improving Access to Medicines

We strive to improve access to medicines through the development and provision of innovative medicines.

News Release
Latest News
Information

December 11, 2019

Recent hhc Activities“"Painting Exhibition of Children with Cancer" at Eisai Headquarters and Tsukuba Research Laboratories”
November 27, 2019

Recent hhc Activities ”For Future Medical Professionals : Medication Seminar at Tsukuba Kids Medical University”
November 7, 2019

Recent hhc Activities ”Lecture Held at Tsukuba Research Laboratories by Inviting Representative Director of Cancer Parents”
October 31, 2019

IR “Second Quarter Financial Results Briefing for the Fiscal Year Ending March 31, 2019 [Material, Webcast]”
October 31, 2019

About Eisai “Corporate Governance Report Notice”

Eisai at a Glance

Eisai Group Worldwide

About Eisai

About Eisai TOP

Our pursuit of human health care (hhc)

Eisai's hhc Philosophy

Eisai's hhc Philosophy TOP

Investors

Sustainability

Making our medicines available to those who need them

28 countries 1.94 billion tablets

Number of countries supplied with lymphatic filariasis treatment
and volume supplied (as of December 2019)

Eisai is promoting initiatives for improving access to medicines to contribute to people in developing and emerging countries

Sustainability TOP